MedTrace Logo

Integrating Combined Therapies for Persons With Co-occurring Disorders

NCT02598518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2018-06-29

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness and implementability of ICT for co-occurring alcohol use and mental health disorders within community addiction treatment, as delivered by routine community addiction clinicians.

Conditions

Interventions

BEHAVIORAL

Integrating Combined Therapies

Individual Integrating Combined Therapies, approximately 10 sessions, one session per week

BEHAVIORAL

Standard Care

Standard Care, individual or group therapy, approximately 9 hours per week for 3 months.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Stanford University

    lead OTHER

Principal Investigators

  • Mark P. McGovern, Ph.D. · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-09-30
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02598518 on ClinicalTrials.gov